ORMP (Oramed) Bozor qiymatining balans qiymatiga nisbati

oramed.com (ORMP) kompaniyasining rasmiy ramzlari

Oramed Pharmaceuticals (ORMP) kompaniyasining joriy narxlar grafigi qat'iy harorat nazoratiga ega bo'lgan oral protein yetkazib berish tizimini ishlab chiqayotgan kompaniya dinamikasini aks ettiradi, bu esa 0.54 darajasida yuqori foydani ta'minlaydi. Biznes diabet bozoriga inyeksiyalar o'rniga tabletkalar yaratish orqali tadqiqot risklarini minimallashtiradi. Yirik fondlar nazarida innovator sifatidagi barqaror imij brendning uzoq muddatli ishonchliligini tasdiqlaydi.

ORMP oramed.com: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida

Oramed Pharmaceuticals (ORMP) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi oramed.com|ORMP - Prognoz darajalari grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Oramed Pharma|ORMP - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Oramed Pharmaceuticals|ORMP - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati oramed.com|ORMP - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Oramed Pharmaceuticals|ORMP - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati oramed.com|ORMP - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Oramed Pharma
Kompaniyaning dastlabki tahlili:Oramed - ORMP
oramed.com original mahsuloti

Ushbu ko'rsatkich Oramed Pharmaceuticals (ORMP) kompaniyasining umumiy bozor qiymatini uning umumiy kapitali bilan solishtiradi. Hisob-kitob bozor narxining sof aktivlarga nisbatini aniqlab, aksiyalarning haddan tashqari qimmat baholanganlik darajasini belgilaydi. Bozor kapitalizatsiyasining balans qiymatiga nisbatini tahlil qilish orqali investor real resurslar va bozor kutuvlari o'rtasidagi farqni ko'rishi mumkin. Oramed Pharmaceuticals (ORMP) uchun ushbu tafovut oral insulin ishlab chiqilishi atrofidagi spekulyatsiyalar tufayli yuzaga kelgan. Grafik chizig'ining tebranishlari aktivlarning joriy qiymatidan ko'ra, dori vositasining muvaffaqiyatiga bo'lgan tartibga soluvchi ishonchni aks ettiradi.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Haleon plc (HLN)|KVUE (kenvue.com) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HYFT (ipatherapeutics.com)|ABVC: Bozor qiymatining balans qiymatiga nisbati|Cumberland Pharmaceuticals Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Quantum BioPharma Limited (QNTM)|FGEN - Balans qiymatiga nisbatan bozor qiymati|TELO: Bozor kapitallashuvining balans qiymatiga nisbati|RANI (Rani Therapeutics Holdings, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati SNYR|Kapitallashuvning sof aktivlarga nisbati Rallybio Corp.|Lexaria Bioscience - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Pulmatrix Corporation (PULM)|PTHL - Bozor kapitallashuvining balans qiymatiga nisbati|APM - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Lyra Therapeutics (LYRA)|IBO: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati tnfpharma.com (TNFA)|cbdMD (YCBD) - Sof aktivlarga nisbatan bozor kapitallashuvi|PRFX - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Auris Medical|Bozor kapitallashuvining balans qiymatiga nisbati LIPO|Bozor kapitallashuvining balans qiymatiga nisbati OPTN (OptiNose Inc)|Bozor qiymatining balans qiymatiga nisbati Pieris|Procaps Group Corp - Balans qiymatiga nisbatan bozor qiymati|PTPI: Bozor qiymatining balans qiymatiga nisbati|QLI - Kapitallashuvning sof aktivlarga nisbati|SLRN: Bozor kapitallashuvining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Bozor kapitallashuvining balans qiymatiga nisbati